Insurance disclosures
Applicants cannot decide that a medical consultation or diagnosis is unimportant when its disclosure is required.
As a lawyer working in the insurance industry, I find it refreshing to read a Supreme Court decision concerning insurance rather than another politically charged controversy. The Court’s 6 October announcement of its ruling in Heirs of Monera v Manila Bankers Life Insurance Corporation and Meycauayan Rural Bank Inc. (G.R. 246446, 28 January 2026), offers an opportunity to examine the responsibilities of applicants and insurers before coverage begins.
The case involved credit-life insurance intended to settle a borrower’s outstanding debt upon his death. Monera signed a health declaration without disclosing prior surgery, medical consultations and a cancer diagnosis. After he died, the insurer denied the claim, leaving his heirs facing the consequences of an unpaid loan.
The Court upheld the insurer’s position because the undisclosed information was material to its assessment of the application. Materiality means that information could reasonably influence whether an insurer accepts the risk or charges a different premium. The Court reiterated that concealment, whether intentional or unintentional, can justify rescission without requiring proof that the applicant intended to deceive.
This principle is not new, having appeared in Sunlife Assurance v Bacani (G.R. 105135, 22 June 1995). Applicants cannot decide that a medical consultation or diagnosis is unimportant when its disclosure is required. Honest answers allow insurers to evaluate risks and offer appropriate terms.
The more difficult issue concerns protection against contesting a life policy after two years. Monera’s policies lasted only two and three months, and the Court held that the two-year incontestability provision did not apply to these short-term contracts. Justice Marvic Leonen dissented, emphasizing the insurer’s duty to exercise greater diligence before approving an application.
Consider Juan de la Cruz, who applies for credit-life insurance while obtaining a bank loan. If he discloses recent surgery and ongoing treatment, the underwriter should seek clarification and, where warranted, relevant medical records with his authorization. Those answers should not be overlooked merely because a standard form has been signed and the premium collected.
If Juan conceals that information despite clear questions, he risks leaving his family without the protection he expected. However, an insurer should distinguish an undisclosed fact from information already supplied but insufficiently examined. Responsible underwriting begins when the application is received, rather than only when a claim makes investigation urgent.
My humble reading is that Monera reinforces established disclosure rules while highlighting the difficulty of applying incontestability protection to short-term coverage. It should be read alongside Manila Bankers Life Insurance Corporation v Aban (G.R. 175666, 29 July 2013), which emphasized responsibilities on both sides, rather than treated as a blanket abandonment of earlier safeguards. Life underwriters should scrutinize applications carefully, because the best protection for Juan and his insurer is a sound assessment before coverage begins.
For comments, email him at darren.dejesus@gmail.com.